Vikram Ranade

Vik joined Tessera in 2020 as the Head of Corporate Development. Vik drives corporate strategy, business development, and investor relations for Tessera.

Vik was previously at McKinsey & Company, where he was an Associate Partner in the healthcare practice. At McKinsey, Vik worked with large biopharma and early-stage biotech companies on strategy, M&A, and R&D topics. He led diligence efforts for over $15B in completed deals and advised on clinical strategy for more than 20 programs. Vik also co-led McKinsey’s Center for Asset Optimization, which focuses on clinical-stage asset development strategy. Vik holds a Ph.D. in Genetics and Development from Columbia University, where he studied transcriptional regulation of developmentally important genes at the molecular level. He has a B.S. in biochemistry from Brandeis University, where he was awarded highest honors for his research on DNA damage repair pathways.